Stocktoria
Quanterix Corp QTRX
Nasdaq · stock · Laboratory Analytical Instruments · website · IPO 2017-12-07
Quanterix Corp financials (annual)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $138.9M | $137.4M | $122.4M | $105.5M | $110.6M | $86.4M | $56.7M | $37.6M | $22.9M |
| Gross profit | $65.0M | $83.1M | $74.2M | $45.4M | $61.7M | $48.2M | $26.8M | $17.9M | $10.0M |
| R&D expense | $35.9M | $31.1M | $26.1M | $26.8M | $28.0M | $20.2M | $16.2M | $15.8M | $16.3M |
| SG&A expense | $138.0M | $101.6M | $89.1M | $91.9M | $92.3M | $59.6M | $52.2M | $33.7M | $19.7M |
| Operating income | -$125.5M | -$52.6M | -$46.0M | -$104.3M | -$58.6M | -$31.6M | -$41.6M | -$31.6M | -$26.0M |
| Income tax | -$5.1M | $434,000 | $719,000 | $164,000 | -$36,000 | -$376,000 | -$187,000 | $25,000 | $0 |
| Net income | -$107.2M | -$38.5M | -$28.4M | -$99.6M | -$57.7M | -$31.5M | -$40.8M | -$31.5M | -$27.0M |
| EPS (diluted) | $-2.51 | $-1.00 | $-0.75 | $-2.69 | $-1.60 | $-1.07 | $-1.63 | — | — |
| Operating cash flow | -$77.2M | -$35.2M | -$18.8M | -$48.6M | -$47.9M | -$23.4M | -$26.2M | -$28.7M | -$22.1M |
| Free cash flow | -$79.8M | -$38.5M | -$22.7M | -$60.2M | -$61.5M | -$27.3M | -$37.0M | -$30.2M | -$23.2M |
| Cash & equivalents | $29.8M | $56.7M | $174.4M | $338.7M | $396.5M | $181.6M | $109.2M | $44.4M | $79.7M |
| Inventory | $54.8M | $32.8M | $26.1M | $16.8M | $22.2M | $14.9M | $10.5M | $5.9M | $3.6M |
| Total assets | $418.8M | $406.5M | $428.6M | $434.2M | $501.5M | $271.0M | $170.0M | $67.6M | $91.8M |
| Total liabilities | $123.0M | $76.5M | $78.6M | $75.3M | $60.6M | $64.9M | $41.3M | $26.5M | $25.9M |
| Shareholders' equity | $295.7M | $330.0M | $350.0M | $357.9M | $442.8M | $206.1M | $128.7M | $41.1M | $65.9M |
Growth · year-over-year · Revenue CAGR 25.3%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +1.1% | +12.3% | +16.0% | -4.6% | +28.0% | +52.2% | +50.8% | +64.5% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.